Search

Angela A. Armstrong

Examiner (ID: 7226, Phone: (571)272-7598 , Office: P/2659 )

Most Active Art Unit
2659
Art Unit(s)
2659, 2641, 2741, 2654, 2626
Total Applications
1003
Issued Applications
675
Pending Applications
123
Abandoned Applications
230

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11414347 [patent_doc_number] => 09561155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-07 [patent_title] => 'Method of reducing cholesterol levels using a human anti-PCSK9 antibody' [patent_app_type] => utility [patent_app_number] => 13/982373 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 70308 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982373 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/982373
Method of reducing cholesterol levels using a human anti-PCSK9 antibody Jan 26, 2012 Issued
Array ( [id] => 9273530 [patent_doc_number] => 08637462 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Methods for reducing platelet counts and/or platelet adhesion by administering a GC-B receptor agonist' [patent_app_type] => utility [patent_app_number] => 13/360039 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5163 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360039 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/360039
Methods for reducing platelet counts and/or platelet adhesion by administering a GC-B receptor agonist Jan 26, 2012 Issued
Array ( [id] => 8312591 [patent_doc_number] => 20120189612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CANCER WHILE PREVENTING OR REDUCING CARDIOTOXICITY AND/OR CARDIOMYOPATHY' [patent_app_type] => utility [patent_app_number] => 13/357668 [patent_app_country] => US [patent_app_date] => 2012-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10056 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13357668 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/357668
COMPOSITIONS AND METHODS FOR TREATING CANCER WHILE PREVENTING OR REDUCING CARDIOTOXICITY AND/OR CARDIOMYOPATHY Jan 24, 2012 Abandoned
Array ( [id] => 8199283 [patent_doc_number] => 20120122786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'Use of Polypeptide Micromolecule MLIF in Preparing Medicine for Preventing and Treating Myocardial Ischemia' [patent_app_type] => utility [patent_app_number] => 13/355873 [patent_app_country] => US [patent_app_date] => 2012-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2156 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122786.pdf [firstpage_image] =>[orig_patent_app_number] => 13355873 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/355873
Method for treating myocardial ischemia Jan 22, 2012 Issued
Array ( [id] => 9749776 [patent_doc_number] => 08841251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-23 [patent_title] => 'Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors' [patent_app_type] => utility [patent_app_number] => 13/346831 [patent_app_country] => US [patent_app_date] => 2012-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 5697 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13346831 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/346831
Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors Jan 9, 2012 Issued
Array ( [id] => 8554708 [patent_doc_number] => 08329177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Method of treating hypertrophic cardiomyopathy' [patent_app_type] => utility [patent_app_number] => 13/334387 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 8004 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13334387 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/334387
Method of treating hypertrophic cardiomyopathy Dec 21, 2011 Issued
Array ( [id] => 8358571 [patent_doc_number] => 20120213730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'ALTERATION OF CELL MEMBRANE FOR NEW FUNCTIONS' [patent_app_type] => utility [patent_app_number] => 13/316915 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9227 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316915 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/316915
Alteration of cell membrane for new functions Dec 11, 2011 Issued
Array ( [id] => 8054039 [patent_doc_number] => 20120076757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/302868 [patent_app_country] => US [patent_app_date] => 2011-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13633 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076757.pdf [firstpage_image] =>[orig_patent_app_number] => 13302868 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/302868
COMPOSITION FOR TRANSMUCOSAL DELIVERY OF POLYPEPTIDES Nov 21, 2011 Abandoned
Array ( [id] => 7791558 [patent_doc_number] => 20120053114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'METHOD' [patent_app_type] => utility [patent_app_number] => 13/291731 [patent_app_country] => US [patent_app_date] => 2011-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10656 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053114.pdf [firstpage_image] =>[orig_patent_app_number] => 13291731 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/291731
METHOD Nov 7, 2011 Abandoned
Array ( [id] => 8208936 [patent_doc_number] => 20120128585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Method of Diagnosing the presence of a tumor in a mammal by assessing CDO expression level' [patent_app_type] => utility [patent_app_number] => 13/286695 [patent_app_country] => US [patent_app_date] => 2011-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 63015 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128585.pdf [firstpage_image] =>[orig_patent_app_number] => 13286695 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/286695
Method of diagnosing the presence of a tumor in a mammal by assessing CDO expression levels Oct 31, 2011 Issued
Array ( [id] => 8290357 [patent_doc_number] => 20120178689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'METHODS OF TREATMENT WITH NATRIURETIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/284529 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 8313 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13284529 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/284529
Methods of treatment of heart failure with natriuretic peptides Oct 27, 2011 Issued
Array ( [id] => 9094880 [patent_doc_number] => 20130274191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR THERAPEUTIC MODULATION OF ALDOSTERONE LEVELS IN HEART DISEASE' [patent_app_type] => utility [patent_app_number] => 13/877955 [patent_app_country] => US [patent_app_date] => 2011-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10448 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877955 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/877955
Compositions comprising b-arrestin 1 and methods of use thereof for therapeutic modulation of aldosterone levels in heart disease Oct 4, 2011 Issued
Array ( [id] => 8939495 [patent_doc_number] => 20130189292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-25 [patent_title] => 'Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions' [patent_app_type] => utility [patent_app_number] => 13/825037 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22801 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825037 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/825037
Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis and related proteins, peptides and compositions Sep 21, 2011 Abandoned
Array ( [id] => 7818520 [patent_doc_number] => 20120065140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Biomarkers for the Diagnosis of Autoimmune Disease' [patent_app_type] => utility [patent_app_number] => 13/231282 [patent_app_country] => US [patent_app_date] => 2011-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12484 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20120065140.pdf [firstpage_image] =>[orig_patent_app_number] => 13231282 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/231282
Biomarkers for the Diagnosis of Autoimmune Disease Sep 12, 2011 Abandoned
Array ( [id] => 9191036 [patent_doc_number] => 20130330352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/819393 [patent_app_country] => US [patent_app_date] => 2011-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24493 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819393 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/819393
TREATMENT OF MYOCARDIAL INFARCTION USING TGF BETA ANTAGONISTS Aug 31, 2011 Abandoned
Array ( [id] => 10874448 [patent_doc_number] => 08899228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-02 [patent_title] => 'Combination pressure therapy for treatment of chronic pain' [patent_app_type] => utility [patent_app_number] => 13/213982 [patent_app_country] => US [patent_app_date] => 2011-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 12544 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13213982 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/213982
Combination pressure therapy for treatment of chronic pain Aug 18, 2011 Issued
Array ( [id] => 7776200 [patent_doc_number] => 20120039839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'Hypoxia Induced Mitogenic Factor' [patent_app_type] => utility [patent_app_number] => 13/211923 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7994 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039839.pdf [firstpage_image] =>[orig_patent_app_number] => 13211923 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/211923
Method for treating pulmonary hypertension Aug 16, 2011 Issued
Array ( [id] => 7784890 [patent_doc_number] => 20120046446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'p16 MEDIATED REGULATION OF NMDA RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/209302 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 15952 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046446.pdf [firstpage_image] =>[orig_patent_app_number] => 13209302 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/209302
p16 MEDIATED REGULATION OF NMDA RECEPTORS Aug 11, 2011 Abandoned
Array ( [id] => 8883569 [patent_doc_number] => 20130156753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/809789 [patent_app_country] => US [patent_app_date] => 2011-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 12839 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809789 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/809789
THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF Jul 30, 2011 Abandoned
Array ( [id] => 10044377 [patent_doc_number] => 09084761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Use of interleukin-15 to treat cardiovascular diseases' [patent_app_type] => utility [patent_app_number] => 13/809154 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7002 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13809154 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/809154
Use of interleukin-15 to treat cardiovascular diseases Jul 7, 2011 Issued
Menu